By Bernadette Toner and Turna Ray
SAN FRANCISCO — A Novartis official said yesterday that the company has identified a genetic marker that it plans to market as a companion diagnostic for a COX-2 inhibitor that was previously withdrawn from several non-US markets due to liver toxicity issues.
Registering provides access to this and other free content.
Already have an account?Login Now.
Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.
Joel Achenbach explores at National Geographic why people find science difficult to believe.
In Science this week: gene linked to expansion of the human neocortex, and more.
The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.